SANTA MONICA, Calif.--(BUSINESS WIRE)--Dr.Evidence™, the leading medical intelligence platform for life sciences companies, today announced a slate of key commercial and technology hires in senior leadership roles. The company is driven to meet new demands for intelligent technology solutions and expertise that empowers clients and partners to generate breakthrough insights faster, more cost efficiently and, ultimately, develop effective products to meet the needs of patients and physicians worldwide.
“The volume and complexity of medical information is growing at an exponential pace. Technology needs to evolve faster than ever to turn that data into intelligence and actionable insights,” said Chief Executive Officer, Bob Battista. “We’re thrilled to welcome these leaders to the Dr.Evidence team that expand our expertise and deepen partnerships with our clients to unlock new possibilities in scientific discovery.”
The new hires include:
David Dornstreich, Chief Commercial Officer: Bringing more than 20 years of life science experience, David will lead the Business Development, Client Success, and Marketing teams. Most recently, David was Vice President, Strategic Initiatives and Data Partnerships at Veradigm, an Allscripts company, where he was responsible for data solutions for biopharma business development. Previously, he led growth plans and strategic partnerships for nonprofit medical societies, including ASCO’s CancerLinQ and the American College of Cardiology. David will serve as a member on the company’s executive committee. https://www.linkedin.com/in/david-dornstreich-b8963b2/
Umut Eser, PhD, Chief Innovation Officer: Umut will be responsible for enhancing Dr.Evidence artificial intelligence/machine learning solutions. Umut earned his PhD in Applied Physics from Stanford University and was a Postdoctoral Research Scientist in Genetics at Harvard University. Prior to joining Dr.Evidence, Umut was Head of Machine Learning Research at Cellarity. https://www.linkedin.com/in/umuteser/
Arturo Devesa, Head of Search Technology: Arturo joins the team to lead DocSearch™, managing the software engineering team. Arturo’s expertise stems from his time as a research scholar at Stanford University Medical School studying machine learning, as well as his experience as an instructor in Statistics and Information Technology at Florida Atlantic University. Arturo earned his MS in Mathematical Economics – Econometrics and Applied Statistics at Florida Atlantic University. Prior to joining Dr.Evidence, Arturo served as Founder & CEO of MedWhat, an intelligent personal medical and health assistant. https://www.linkedin.com/in/arturo-devesa-13813130/
“At Dr.Evidence we are committed to continually investing in talent and technology,” stated Joseph A. Boystak, Chairman of the Board. “We are confident this combination, in collaboration with our clients and partners, will result in remarkable achievements.”
To further demonstrate the company’s commitment to unlocking possibilities in science, Dr.Evidence recently rebranded with a new visual identity and articulation of the organization’s promise: Accelerated Impact™. The new logo, with its “dot,” is designed to represent the point of clarity that Dr.Evidence brings to bear in a growing sea of evidence.
About Dr.Evidence™
Dr.Evidence™ is the leading medical intelligence platform for Life Sciences companies that enables users to identify breakthrough insights grounded in the vast universe of published medical information, real-world evidence and proprietary data. It pushes the boundaries of healthcare technology and allows for new possibilities in science, enabling more informed decision making and faster time-to-market for accelerated impact.
